296 related articles for article (PubMed ID: 15979379)
1. Intrabodies as drug discovery tools and therapeutics.
Stocks M
Curr Opin Chem Biol; 2005 Aug; 9(4):359-65. PubMed ID: 15979379
[TBL] [Abstract][Full Text] [Related]
2. Intrabodies: production and promise.
Stocks MR
Drug Discov Today; 2004 Nov; 9(22):960-6. PubMed ID: 15539139
[TBL] [Abstract][Full Text] [Related]
3. Intracellular antibodies: a revolution waiting to happen?
Stocks M
Curr Opin Mol Ther; 2006 Feb; 8(1):17-23. PubMed ID: 16506521
[TBL] [Abstract][Full Text] [Related]
4. The potential of intracellular antibodies for therapeutic targeting of protein-misfolding diseases.
Cardinale A; Biocca S
Trends Mol Med; 2008 Sep; 14(9):373-80. PubMed ID: 18693139
[TBL] [Abstract][Full Text] [Related]
5. Intrabodies: turning the humoral immune system outside in for intracellular immunization.
Marasco WA
Gene Ther; 1997 Jan; 4(1):11-5. PubMed ID: 9068790
[TBL] [Abstract][Full Text] [Related]
6. Intracellular antibodies (intrabodies) and their therapeutic potential.
Lo AS; Zhu Q; Marasco WA
Handb Exp Pharmacol; 2008; (181):343-73. PubMed ID: 18071953
[TBL] [Abstract][Full Text] [Related]
7. Intrabody applications in neurological disorders: progress and future prospects.
Miller TW; Messer A
Mol Ther; 2005 Sep; 12(3):394-401. PubMed ID: 15964243
[TBL] [Abstract][Full Text] [Related]
8. Biopharmaceutical drug discovery using novel protein scaffolds.
Gill DS; Damle NK
Curr Opin Biotechnol; 2006 Dec; 17(6):653-8. PubMed ID: 17055245
[TBL] [Abstract][Full Text] [Related]
9. Engineered protein scaffolds as next-generation antibody therapeutics.
Gebauer M; Skerra A
Curr Opin Chem Biol; 2009 Jun; 13(3):245-55. PubMed ID: 19501012
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic advances in rheumatology with the use of recombinant proteins.
Rothe A; Power BE; Hudson PJ
Nat Clin Pract Rheumatol; 2008 Nov; 4(11):605-14. PubMed ID: 18813220
[TBL] [Abstract][Full Text] [Related]
11. The intracellular antibody capture technology: towards the high-throughput selection of functional intracellular antibodies for target validation.
Visintin M; Quondam M; Cattaneo A
Methods; 2004 Oct; 34(2):200-14. PubMed ID: 15312673
[TBL] [Abstract][Full Text] [Related]
12. Intracellular antibodies and challenges facing their use as therapeutic agents.
Lobato MN; Rabbitts TH
Trends Mol Med; 2003 Sep; 9(9):390-6. PubMed ID: 13129705
[TBL] [Abstract][Full Text] [Related]
13. Ribosome display: next-generation display technologies for production of antibodies in vitro.
He M; Khan F
Expert Rev Proteomics; 2005 Jun; 2(3):421-30. PubMed ID: 16000087
[TBL] [Abstract][Full Text] [Related]
14. Antibodies and genetically engineered related molecules: production and purification.
Roque AC; Lowe CR; Taipa MA
Biotechnol Prog; 2004; 20(3):639-54. PubMed ID: 15176864
[TBL] [Abstract][Full Text] [Related]
15. Engineering antibodies for clinical applications.
Jain M; Kamal N; Batra SK
Trends Biotechnol; 2007 Jul; 25(7):307-16. PubMed ID: 17512622
[TBL] [Abstract][Full Text] [Related]
16. Tailor-made antibody therapeutics.
Chowdhury PS; Wu H
Methods; 2005 May; 36(1):11-24. PubMed ID: 15848071
[TBL] [Abstract][Full Text] [Related]
17. Antibody engineering and modification technologies.
Filpula D
Biomol Eng; 2007 Jun; 24(2):201-15. PubMed ID: 17466589
[TBL] [Abstract][Full Text] [Related]
18. Selection and use of intracellular antibodies (intrabodies).
Moutel S; Nizak C; Perez F
Methods Mol Biol; 2012; 907():667-79. PubMed ID: 22907379
[TBL] [Abstract][Full Text] [Related]
19. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
20. Functional proteomic screens in therapeutic protein drug discovery.
Ilag LL
Curr Opin Mol Ther; 2005 Dec; 7(6):538-42. PubMed ID: 16370376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
